Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene-edited pigs are resistant to PRRS, study finds
PRRS is an economically devastating disease that costs the pig industry some $2.5 billion in the US and Europe alone.

Results show potential of technique to benefit the pork industry

Scientists have used gene-editing techniques to create pigs that are resistant to Porcine Reproductive and Respiratory Syndrome (PRRS).

In a first-of-its-kind study, researchers exposed these pigs to the virus to see if they became infected. They found that none of the pigs became ill when exposed to the virus, nor did blood tests find any trace of infection.

Dr Christine Tait-Burkard, of the University of Edinburgh’s Roslin Institute, said the results were exciting but stressed that it will still be many years before we’ll be producing food from PRRS-resistant pigs.

“First and foremost we need broader public discussion on the acceptability of gene-edited meat entering our food chain, to help inform political leaders on how these techniques should be regulated,” she said. “We also need to carry out long-term studies to confirm that these genetic changes do not have any unforeseen adverse effects on the animals.

PRRS is an economically devastating disease that costs the pig industry some $2.5 billion in the US and Europe alone. Most vaccines have not been successful in preventing the spread of the virus, which continues to evolve.

The virus infects pigs using a receptor in their cells’ surface called CD163. Researchers at the University of Edinburgh’s Roslin Institute used gene-editing techniques to remove a small section of this gene.

Previous studies have shown that cells from these animals were resistant to the virus in lab tests. But this is the first time researchers have exposed these pigs to the virus to see if they become infected.

The study was funded by the Biotechnology and Biological Sciences Research Council and Genus PLC and is published in the Journal of Virology.

Genus chief scientific officer Jonathan Lightner said: “These results are very exciting and further underscore the potential, through gene editing, to provide incredible benefits to the global pork industry, and society as a whole, by improving animal health.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'